UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Endometrial cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

Annals of oncology, 2022-09, Vol.33 (9), p.860-877

2022

Volltextzugriff (PDF)

Practical guidance for mismatch repair-deficiency testing in endometrial cancer

Annals of oncology, 2017-01, Vol.28 (1), p.96-102

2017

Volltextzugriff (PDF)

L1 cell adhesion molecule is a strong predictor for distant recurrence and overall survival in early stage endometrial cancer: Pooled PORTEC trial results

European journal of cancer (1990), 2014-10, Vol.50 (15), p.2602-2610

2014

Volltextzugriff (PDF)

Improved survival of patients with cervical cancer treated with image-guided brachytherapy compared with conventional brachytherapy

Gynecologic oncology, 2014-11, Vol.135 (2), p.231-238

2014

Volltextzugriff (PDF)

Molecular risk stratification to direct therapy in endometrial cancer: ready for the clinic?

Annals of oncology, 2018-05, Vol.29 (5), p.1081-1082

2018

Volltextzugriff (PDF)

SP-0604 THIS HOUSE BELIEVES THAT THERE IS STILL A ROLE FOR RT IN INTERMEDIATE RISK ENDOMETRIAL CANCER – FOR THE MOTION

Radiotherapy and oncology, 2012-05, Vol.103, p.S238-S238

Creutzberg, C.L

2012

Volltextzugriff (PDF)

130 VAGINAL BRACHYTHERAPY SHOULD BE THE STANDARD ADJUVANT TREATMENT

Radiotherapy and oncology, 2012-05, Vol.103, p.S52-S53

Creutzberg, C.L

2012

Volltextzugriff (PDF)

Risk factors and treatment for recurrent vulvar squamous cell carcinoma

Critical reviews in oncology/hematology, 2016-10, Vol.106, p.1-13

2016

Volltextzugriff (PDF)

Tumour-free margins in vulvar squamous cell carcinoma: Does distance really matter?

European journal of cancer (1990), 2016-09, Vol.65, p.139-149

2016

Volltextzugriff (PDF)

Less-favourable prognosis for low-risk endometrial cancer patients with a discordant pre- versus post-operative risk stratification

European journal of cancer (1990), 2017-06, Vol.78, p.82-90

2017

Volltextzugriff (PDF)

OC-0551: Advantage of IMPT over IMRT in treatment of gynaecological cancer with para-aortic nodal involvement

Radiotherapy and oncology, 2016-04, Vol.119, p.S263-S264

2016

Volltextzugriff (PDF)

Markers of the p53 pathway further refine molecular profiling in high-risk endometrial cancer: A Trans PORTEC initiative

Gynecologic oncology, 2017-08, Vol.146 (2), p.327-333

2017

Volltextzugriff (PDF)

PO-0763: Ruthenium-106 brachytherapy for choroidal melanoma: high efficacy with improved visual outcome

Radiotherapy and oncology, 2016-04, Vol.119, p.S357-S358

2016

Volltextzugriff (PDF)

Quantification of LVSI Improves Its Strength as Prognostic Factor for Recurrence in Stage I Endometrial Cancer Patients Treated in the PORTEC Trials

International journal of radiation oncology, biology, physics, 2014-09, Vol.90 (1), p.S110-S111

2014

Volltextzugriff (PDF)

PD-0436: Long-term bowel and bladder symptoms after pelvic radiotherapy or vaginal brachytherapy in the PORTEC-2 trial

Radiotherapy and oncology, 2015-04, Vol.115, p.S213-S213

2015

Volltextzugriff (PDF)

Second Cancers in Patients Treated With Surgery and Radiation Therapy for Rectal or Endometrial Cancer in the Randomized TME, PORTEC-1, and PORTEC-2 Trials

International journal of radiation oncology, biology, physics, 2014-09, Vol.90 (1), p.S85-S86

2014

Volltextzugriff (PDF)

Consensus Guidelines for Delineation of Clinical Target Volume for Intensity-Modulated Pelvic Radiation Therapy in Postoperative Treatment of Endometrial and Cervical Cancer- An Update

International journal of radiation oncology, biology, physics, 2014-09, Vol.90 (1), p.S109-S109

2014

Volltextzugriff (PDF)

PD-0468: Long-term risk of secondary skin cancers after radiation therapy for Hodgkin lymphoma

Radiotherapy and oncology, 2013-03, Vol.106, p.S182-S182

2013

Volltextzugriff (PDF)

PD-0521: Impact of cardiac screening on satisfaction with information provision in Hodgkin Lymphoma survivors

Radiotherapy and oncology, 2014, Vol.111, p.S205-S206

2014

Volltextzugriff (PDF)

Combined E‐cadherin, α‐catenin, and β‐catenin expression is a favorable prognostic factor in endometrial carcinoma

International journal of gynecological cancer, 2006-05, Vol.16 (3), p.1379-1385

2006

Volltextzugriff (PDF)

9416 POSTER Limb-sparing Surgery and Radiotherapy for Soft Tissue Sarcomas of the Extremities

European journal of cancer (1990), 2011, Vol.47, p.S667-S667

2011

Volltextzugriff (PDF)

PD-0302 IMPROVED RISK ASSESSMENT OF ENDOMETRIAL CANCER PATIENTS BY ANALYSIS OF MSI, PI3K-AKT, WNT AND P53 PATHWAY

Radiotherapy and oncology, 2012-05, Vol.103, p.S119-S120

2012

Volltextzugriff (PDF)

Efficacy and safety of durvalumab with olaparib in metastatic or recurrent endometrial cancer (phase II DOMEC trial)

Gynecologic oncology, 2022-05, Vol.165 (2), p.223-229

2022

Volltextzugriff (PDF)

Red Blood Cell Transfusion Practices for Cervix Cancer Patients Undergoing Radiotherapy: An International Delphi Consensus Study

International journal of radiation oncology, biology, physics, 2020-11, Vol.108 (3), p.e465-e465

2020

Volltextzugriff (PDF)

1 – 25 von 61

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(61)
Mit Volltextzugriff
(60)

Publikationsform

Artikel
(61)

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(24)
Science & Technology
(24)
Hematology, Oncology And Palliative Medicine
(23)
Oncology
(23)
Humans
(21)
Female
(20)
Adult
(9)
Endometrial Cancer
(9)
Middle Aged
(9)
Aged
(8)
Obstetrics & Gynecology
(7)
Prognosis
(7)
Endometrial Neoplasms - Pathology
(5)
Radiology
(5)
Retrospective Studies
(5)
Aged, 80 And Over
(4)
Biological And Medical Sciences
(4)
Disease-Free Survival
(4)
Immunohistochemistry
(4)
Medical Sciences
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Endometrial cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

Practical guidance for mismatch repair-deficiency testing in endometrial cancer

L1 cell adhesion molecule is a strong predictor for distant recurrence and overall survival in early stage endometrial cancer: Pooled PORTEC trial results

Improved survival of patients with cervical cancer treated with image-guided brachytherapy compared with conventional brachytherapy

Molecular risk stratification to direct therapy in endometrial cancer: ready for the clinic?

SP-0604 THIS HOUSE BELIEVES THAT THERE IS STILL A ROLE FOR RT IN INTERMEDIATE RISK ENDOMETRIAL CANCER – FOR THE MOTION

130 VAGINAL BRACHYTHERAPY SHOULD BE THE STANDARD ADJUVANT TREATMENT

Risk factors and treatment for recurrent vulvar squamous cell carcinoma

Tumour-free margins in vulvar squamous cell carcinoma: Does distance really matter?

Less-favourable prognosis for low-risk endometrial cancer patients with a discordant pre- versus post-operative risk stratification

OC-0551: Advantage of IMPT over IMRT in treatment of gynaecological cancer with para-aortic nodal involvement

Markers of the p53 pathway further refine molecular profiling in high-risk endometrial cancer: A Trans PORTEC initiative

PO-0763: Ruthenium-106 brachytherapy for choroidal melanoma: high efficacy with improved visual outcome

Quantification of LVSI Improves Its Strength as Prognostic Factor for Recurrence in Stage I Endometrial Cancer Patients Treated in the PORTEC Trials

PD-0436: Long-term bowel and bladder symptoms after pelvic radiotherapy or vaginal brachytherapy in the PORTEC-2 trial

Second Cancers in Patients Treated With Surgery and Radiation Therapy for Rectal or Endometrial Cancer in the Randomized TME, PORTEC-1, and PORTEC-2 Trials

Consensus Guidelines for Delineation of Clinical Target Volume for Intensity-Modulated Pelvic Radiation Therapy in Postoperative Treatment of Endometrial and Cervical Cancer- An Update

PD-0468: Long-term risk of secondary skin cancers after radiation therapy for Hodgkin lymphoma

PD-0521: Impact of cardiac screening on satisfaction with information provision in Hodgkin Lymphoma survivors

Combined E‐cadherin, α‐catenin, and β‐catenin expression is a favorable prognostic factor in endometrial carcinoma

p53 immunohistochemistry in endometrial cancer: clinical and molecular correlates in the PORTEC-3 trial

9416 POSTER Limb-sparing Surgery and Radiotherapy for Soft Tissue Sarcomas of the Extremities

PD-0302 IMPROVED RISK ASSESSMENT OF ENDOMETRIAL CANCER PATIENTS BY ANALYSIS OF MSI, PI3K-AKT, WNT AND P53 PATHWAY

Efficacy and safety of durvalumab with olaparib in metastatic or recurrent endometrial cancer (phase II DOMEC trial)

Red Blood Cell Transfusion Practices for Cervix Cancer Patients Undergoing Radiotherapy: An International Delphi Consensus Study

Suchergebnisse filtern